Cardiac autonomic modulation in hypertensive patients with Chagas' disease

Adriana Nazaré Miziara1, Rodrigo Juliano Molina, Bruno Doriguetto Couto Ferreira

  • 1Faculdade de Medicina do Triângulo Mineiro, Disciplina de Doenças Infecciosas e Parasitárias, Departamento de Clínica Médica, Avenida Getúlio Guarita, S/N, Caixa Postal: 118, Uberaba, Minas Gerais 38025-440, Brazil.

Acta Tropica
|December 17, 2005
PubMed

Insights

Chagasic-hypertensive patients exhibit impaired cardiac parasympathetic modulation at rest and during orthostatic stress. This autonomic dysfunction affects heart rate variability in these individuals.

Area of Science:

  • Cardiology
  • Autonomic Nervous System
  • Public Health

Background:

  • Arterial hypertension and Chagas' disease are common in Latin America.
  • Both conditions can lead to cardiac autonomic dysfunction.
  • This study investigates cardiac autonomic modulation in patients with both conditions.

Purpose of the Study:

  • To analyze cardiac autonomic modulation patterns in patients with coexisting hypertension and Chagas' disease.
  • To compare autonomic function between healthy controls, hypertensive patients, chagasic patients, and chagasic-hypertensive patients.

Main Methods:

  • 120 subjects without left ventricular dysfunction were divided into four groups.
  • Autoregressive spectral analysis of heart rate variability was performed.
  • Measurements were taken at baseline, during cold face test, and passive tilt test.

Main Results:

  • Chagasic-hypertensive patients showed reduced high-frequency heart rate variability at baseline.
  • No significant differences in spectral parameters were observed during the cold face test.
  • Hypertensive, chagasic, and chagasic-hypertensive groups had blunted responses to passive tilt test compared to controls.

Conclusions:

  • Chagasic-hypertensive patients demonstrate impaired cardiac parasympathetic modulation.
  • This impairment is evident under baseline conditions and during orthostatic stress.
  • Findings highlight the combined impact of hypertension and Chagas' disease on cardiac autonomic control.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...